Literature DB >> 23920020

Brain imaging and cognitive predictors of stroke and Alzheimer disease in the Framingham Heart Study.

Galit Weinstein1, Alexa S Beiser, Charles Decarli, Rhoda Au, Philip A Wolf, Sudha Seshadri.   

Abstract

BACKGROUND AND
PURPOSE: Exposure to vascular risk factors has a gradual deleterious effect on brain MRI and cognitive measures. We explored whether a pattern of these measures exists that predicts stroke and Alzheimer disease (AD) risk.
METHODS: A cognitive battery was administered to 1679 dementia and stroke-free Framingham offspring (age, >55 years; mean, 65.7±7.0) between 1999 and 2004; participants were also free of other neurological conditions that could affect cognition and >90% also had brain MRI examination. We related cognitive and MRI measures to risks of incident stroke and AD ≤10 years of follow-up. As a secondary analysis, we explored these associations in The Framingham Heart Study original cohort (mean age, 67.5±7.3 and 84.8±3.3 years at the cognitive assessment and MRI examination, respectively).
RESULTS: A total of 55 Offspring participants sustained strokes and 31 developed AD. Offspring who scored <1.5 SD below predicted mean scores, for age and education, on an executive function test, had a higher risk of future stroke (hazard ratio [HR], 2.27; 95% confidence interval [CI], 1.06-4.85) and AD (HR, 3.60; 95% CI, 1.52-8.52); additional cognitive tests also predicted AD. Participants with low (<20 percentile) total brain volume and high (>20 percentile) white matter hyperintensity volume had a higher risk of stroke (HR, 1.97; 95% CI, 1.03-3.77 and HR, 2.74; 95% CI, 1.51-5.00, respectively) but not AD. Hippocampal volume at the bottom quintile predicted AD in the offspring and original cohorts (HR, 4.41; 95% CI, 2.00-9.72 and HR, 2.37; 95% CI, 1.12-5.00, respectively). A stepwise increase in stroke risk was apparent with increasing numbers of these cognitive and imaging markers.
CONCLUSIONS: Specific patterns of cognitive and brain structural measures observed even in early aging predict stroke risk and may serve as biomarkers for risk prediction.

Entities:  

Keywords:  Alzheimer disease; cognition; magnetic resonance imaging; stroke

Mesh:

Year:  2013        PMID: 23920020      PMCID: PMC3974341          DOI: 10.1161/STROKEAHA.113.000947

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  51 in total

1.  Probability of stroke: a risk profile from the Framingham Study.

Authors:  P A Wolf; R B D'Agostino; A J Belanger; W B Kannel
Journal:  Stroke       Date:  1991-03       Impact factor: 7.914

2.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

Review 3.  Incidence of mild cognitive impairment: a systematic review.

Authors:  Tobias Luck; Melanie Luppa; Susanne Briel; Steffi G Riedel-Heller
Journal:  Dement Geriatr Cogn Disord       Date:  2010-02-11       Impact factor: 2.959

4.  Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes.

Authors:  Gloria C Chiang; Philip S Insel; Duygu Tosun; Norbert Schuff; Diana Truran-Sacrey; Sky Raptentsetsang; Clifford R Jack; Michael W Weiner
Journal:  Radiology       Date:  2011-04-05       Impact factor: 11.105

5.  Interpreting incremental value of markers added to risk prediction models.

Authors:  Michael J Pencina; Ralph B D'Agostino; Karol M Pencina; A Cecile J W Janssens; Philip Greenland
Journal:  Am J Epidemiol       Date:  2012-08-08       Impact factor: 4.897

6.  Predictors of brain morphology for the men of the NHLBI twin study.

Authors:  C DeCarli; B L Miller; G E Swan; T Reed; P A Wolf; J Garner; L Jack; D Carmelli
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

7.  Dementia after stroke: the Framingham Study.

Authors:  Cristina S Ivan; Sudha Seshadri; Alexa Beiser; Rhoda Au; Carlos S Kase; Margaret Kelly-Hayes; Philip A Wolf
Journal:  Stroke       Date:  2004-04-29       Impact factor: 7.914

8.  Assessment of cerebral small vessel disease predicts individual stroke risk.

Authors:  Mariëlle M F Poels; Ewout W Steyerberg; Renske G Wieberdink; Albert Hofman; Peter J Koudstaal; M Arfan Ikram; Monique M B Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-08-23       Impact factor: 10.154

9.  New norms for a new generation: cognitive performance in the framingham offspring cohort.

Authors:  Rhoda Au; Sudha Seshadri; Philip A Wolf; Merrill Elias; Penelope Elias; Lisa Sullivan; Alexa Beiser; Ralph B D'Agostino
Journal:  Exp Aging Res       Date:  2004 Oct-Dec       Impact factor: 1.645

10.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

View more
  21 in total

Review 1.  Cognitive impairment and risk of future stroke: a systematic review and meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Keun-Sik Hong; Yi-Ling Wu; Hsing-Cheng Liu; Neal M Rao; Bruce Ovbiagele
Journal:  CMAJ       Date:  2014-08-25       Impact factor: 8.262

2.  Long-term exposure to fine particulate matter, residential proximity to major roads and measures of brain structure.

Authors:  Elissa H Wilker; Sarah R Preis; Alexa S Beiser; Philip A Wolf; Rhoda Au; Itai Kloog; Wenyuan Li; Joel Schwartz; Petros Koutrakis; Charles DeCarli; Sudha Seshadri; Murray A Mittleman
Journal:  Stroke       Date:  2015-05       Impact factor: 7.914

3.  Cognitive correlates of white matter lesion load and brain atrophy: the Northern Manhattan Study.

Authors:  Chuanhui Dong; Nooshin Nabizadeh; Michelle Caunca; Ying Kuen Cheung; Tatjana Rundek; Mitchell S V Elkind; Charles DeCarli; Ralph L Sacco; Yaakov Stern; Clinton B Wright
Journal:  Neurology       Date:  2015-07-08       Impact factor: 9.910

4.  Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: The Framingham Study.

Authors:  Galit Weinstein; Kendra Davis-Plourde; Jayandra J Himali; Shira Zelber-Sagi; Alexa S Beiser; Sudha Seshadri
Journal:  Liver Int       Date:  2019-06-26       Impact factor: 5.828

5.  Body mass index is associated with cortical thinning with different patterns in mid- and late-life.

Authors:  M E Shaw; P S Sachdev; W Abhayaratna; K J Anstey; N Cherbuin
Journal:  Int J Obes (Lond)       Date:  2017-10-10       Impact factor: 5.095

6.  Arterial wall function is associated with cognitive performance primarily in elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Salo Haratz; David Tanne; James Schmeidler; Shai Efrati; Clive Rosendorff; Michal Schnaider Beeri; Jeremy M Silverman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

7.  Racial Differences in Cognitive Function and Risk of Incident Stroke.

Authors:  Kumar B Rajan; Julie A Schneider; Neelum T Aggarwal; Robert S Wilson; Susan A Everson-Rose; Denis A Evans
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-09-19       Impact factor: 2.136

8.  MRI Markers Predict Cognitive Decline Assessed by Telephone Interview: The Northern Manhattan Study.

Authors:  Clinton B Wright; Chuanhui Dong; Michelle R Caunca; Janet DeRosa; Ying Kuen Cheng; Tatjana Rundek; Mitchell S V Elkind; Charles DeCarli; Ralph L Sacco
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Jan-Mar       Impact factor: 2.703

9.  The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Jeremy M Silverman; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-05-14       Impact factor: 4.600

10.  Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.

Authors:  Galit Weinstein; Shira Zelber-Sagi; Sarah R Preis; Alexa S Beiser; Charles DeCarli; Elizabeth K Speliotes; Claudia L Satizabal; Ramachandran S Vasan; Sudha Seshadri
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.